Business Description
BRAIN Biotech AG
ISIN : DE0005203947
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.42 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | -3.08 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -0.63 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.3 | |||||
3-Year EBITDA Growth Rate | 30.1 | |||||
3-Year EPS without NRI Growth Rate | 10.2 | |||||
3-Year FCF Growth Rate | 8.4 | |||||
3-Year Book Growth Rate | -1.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 25.1 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.37 | |||||
9-Day RSI | 35.83 | |||||
14-Day RSI | 36.14 | |||||
6-1 Month Momentum % | -23.5 | |||||
12-1 Month Momentum % | -31.37 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.01 | |||||
Quick Ratio | 1.4 | |||||
Cash Ratio | 0.71 | |||||
Days Inventory | 143.46 | |||||
Days Sales Outstanding | 55.81 | |||||
Days Payable | 72.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.2 | |||||
Shareholder Yield % | -3.04 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.69 | |||||
Operating Margin % | -9.22 | |||||
Net Margin % | -14.53 | |||||
FCF Margin % | -3.34 | |||||
ROE % | -37.31 | |||||
ROA % | -11.34 | |||||
ROIC % | -8.98 | |||||
ROC (Joel Greenblatt) % | -27.04 | |||||
ROCE % | -11.26 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.87 | |||||
PB Ratio | 2.61 | |||||
Price-to-Tangible-Book | 12.89 | |||||
EV-to-EBIT | -7.24 | |||||
EV-to-EBITDA | -32.12 | |||||
EV-to-Revenue | 0.81 | |||||
EV-to-FCF | -22.73 | |||||
Earnings Yield (Greenblatt) % | -13.82 | |||||
FCF Yield % | -3.64 |